Anti-C1q Autoantibody-Binding Engineered scFv C1q-Mimicking Fragment Enhances Disease Progression in Lupus-Prone MRL/lpr Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157048 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Silviya Bradyanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Complement C1q, Single-Chain Antibodies, Autoantibodies, Lupus Erythematosus, Systemic. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund, Bulgaria, Scientific Research, Innovation, and Digitalization for Intelligent Transformation 2021-2027" Programme., Scientific Research, Innovation, and Digitalization for Intelligent Transformation 2021–2027” Programme.
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease characterized by tissue damage in multiple organs caused by autoantibodies and the resulting immune complexes. One possible way for complement system contribution to onset of autoimmune disorder could be realized by the impairment of C1q-mediated apoptotic clearance as part of human homeostasis. The capacity of C1q to bind early apoptotic cells could be decreased or even lost in the presence of anti-C1q antibodies. A monoclonal anti-idiotypic single-chain (scFv) antibody was selected from the phage library Griffin1” to recognize anti-C1q autoantibodies, purified from sera of lupus nephritis patients. Lupus-prone MRL/lpr mice were injected weekly with scFv A1 fragment-binding anti-C1q antibodies. The number of in vitro and ex vivo studies with collected cells, sera, and organs from the treated animals was performed. scFv treatment changed the percentage of different B-, T-, and NK-cell subpopulations as well as plasma cells and plasmablasts in the spleen and bone marrow. An increase in the levels of splenocyte proliferation, anti-C1q antibodies, and the number of plasma cells producing anti-dsDNA and anti-C1q antibodies were also observed in scFv-treated animals. High levels of proteinuria and hematuria combined with unstable levels of IL10 and IFNγ promote the development of severe lupus and shorten the survival of treated MRL/lpr mice. Therapy with the scFv A1 antibody resulted in BCR recognition on the surface of anti-C1q-specific B-cells and had a disease progression effect, enhancing lupus symptoms in the MRL/lpr mouse model of SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
- Department of Biochemistry, Faculty of Biology, Sofia University "St. Kliment Ohridski", 1000 Sofia, Bulgaria.
ORCID-Profile: Nikolina Mihaylova, Nikola Ralchev, Alexandra Kapogianni, Ginka Cholakova, Ivanka Tsacheva
Förderung
- National Science Fund, Bulgaria
- Scientific Research, Innovation, and Digitalization for Intelligent Transformation 2021-2027" Programme.
- Scientific Research, Innovation, and Digitalization for Intelligent Transformation 2021–2027” Programme
Zitieren
APA
Bradyanova, S., Mihaylova, N., Ralchev, N., Kapogianni, A., Cholakova, G., Nikolova-Ganeva, K., Tsacheva, I., & Tchorbanov, A. (2025). Anti-C1q Autoantibody-Binding Engineered scFv C1q-Mimicking Fragment Enhances Disease Progression in Lupus-Prone MRL/lpr Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157048
Vancouver
Bradyanova S, Mihaylova N, Ralchev N, Kapogianni A, Cholakova G, Nikolova-Ganeva K, et al. Anti-C1q Autoantibody-Binding Engineered scFv C1q-Mimicking Fragment Enhances Disease Progression in Lupus-Prone MRL/lpr Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157048
BibTeX
@article{Bradyanova2025,
author = {Bradyanova, Silviya and Mihaylova, Nikolina and Ralchev, Nikola and Kapogianni, Alexandra and Cholakova, Ginka and Nikolova-Ganeva, Kalina and Tsacheva, Ivanka and Tchorbanov, Andrey},
title = {Anti-C1q Autoantibody-Binding Engineered scFv C1q-Mimicking Fragment Enhances Disease Progression in Lupus-Prone MRL/lpr Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157048}
}
EUVIMED